Renin-based blood pressure guidance for ICU shock patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether using a blood test called renin to guide treatment can help stabilize blood pressure in ICU patients with shock. It may help doctors choose the right medications and targets to reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the ICU and still need norepinephrine to keep blood pressure up after fluids
- Your blood pressure goal (mean arterial pressure, MAP) is at least 65 mmHg on treatment
- The ICU team expects you to stay in the ICU for at least 24 hours
- You (or your next of kin) can give consent for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial gives a drug called angiotensin II to people in vasoplegic shock (a type of shock where blood vessels stay too relaxed despite other medicines). It tests how the drug affects a kidney-related hormone (renin) and if it can help raise blood pressure.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This study compares individualized blood pressure goals versus the usual (standard) targets for adults in the ICU with shock. The aim is to see whether tailored blood pressure treatment can improve outcomes by better matching each person’s needs.
This trial studies whether aiming for a higher average blood pressure (using medicines) can better protect kidney function in critically ill adults with shock. You may be asked to have close kidney and heart monitoring while receiving blood-pressure support.
This Phase 3 study tests whether starting a blood-pressure medicine earlier in the emergency room can improve outcomes for people with low blood pressure or shock. It focuses on patients who have already received enough IV fluids and meet specific blood pressure and lab findings.
This study tests whether giving low-dose blood pressure medicines through a standard IV (instead of a larger central line) is safe and effective for patients with shock in the intensive care unit.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.